ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 159 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,751 | +9.7% | 37,950 | -4.7% | 0.00% | 0.0% |
Q1 2023 | $1,596 | -6.8% | 39,811 | +7.6% | 0.00% | 0.0% |
Q4 2022 | $1,713 | -99.9% | 36,986 | -23.7% | 0.00% | -33.3% |
Q3 2022 | $2,007,000 | -9.1% | 48,469 | +31.0% | 0.01% | 0.0% |
Q2 2022 | $2,207,000 | +26.5% | 36,986 | +78.2% | 0.01% | +100.0% |
Q4 2021 | $1,745,000 | +288.6% | 20,757 | +135.8% | 0.00% | +50.0% |
Q1 2018 | $449,000 | – | 8,801 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |